Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Monkeypox skin lesions show full-thickness skin death and swollen skin cells, with the virus found in affected cells.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

The project created a standardized system for classifying skin lesions in lab rats and mice.

The antibody created from BCC tissues reacts similarly to both BCC and hair follicles, suggesting BCC may come from hair follicle cells.

Interface dermatitis is the most common skin change in drug-induced hypersensitivity syndrome.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Skin reactions from cancer treatments might predict how well the treatments work.

Certain microRNAs may help treat alopecia areata by targeting immune pathways.

Nanomedicine-based immunotherapy shows promise in improving tissue repair and regeneration.

The document concludes that choosing the right biopsy site is crucial for accurate alopecia diagnosis, and combining methods can improve results.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

Targeting specific biomarkers and immune signals is more effective and safer for treating inflammatory skin diseases.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Prednisone reduces organ mast cell infiltration but does not alter the abnormal appearance of mast cells in systemic mastocytosis.

Cystic panfolliculoma resembles hair follicle tumors due to specific cell interactions.

IL-17 plays a key role in severe hair loss in chronic alopecia areata.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Immune checkpoint inhibitors can cause skin issues, which may indicate a good cancer response, and dermatologists are important in managing these effects.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

Blood tests can help understand the genetic differences in people with alopecia areata, including how severe it is and if it's inherited.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Alopecia areata is linked to immune-related genes, suggesting JAK inhibitors as a potential treatment.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.